Biohaven Pharmaceutical Holding Co Ltd.(BHVN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BHVN Biohaven Pharmaceutical Holding Co Ltd.

盘前交易 09-16 07:16:09 EDT

12.34

-0.30

-2.37%

盘前12.34

+0.00-0.02%

05:27 EDT

最高12.67	最低11.96	成交量308.29万
今开12.57	昨收12.64	日振幅5.62%
总市值18.56亿	流通市值14.56亿	总股本1.50亿
成交额3,753万	换手率2.61%	流通股本1.18亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BHVN","market":"US","secType":"STK","nameCN":"Biohaven Pharmaceutical Holding Co Ltd.","latestPrice":12.34,"timestamp":1789502400000,"preClose":12.64,"halted":0,"volume":3082898,"hourTrading":{"tag":"盘前","latestPrice":12.3377,"preClose":12.34,"latestTime":"05:27 EDT","volume":4,"amount":49.3577,"timestamp":1789550832889,"change":-0.0023,"changeRate":-0.000186,"amplitude":0.000186},"delay":0,"changeRate":-0.023734177215189927,"floatShares":117986353,"shares":150417084,"eps":-4.480042,"marketStatus":"盘前交易","change":-0.3,"latestTime":"09-16 07:16:09 EDT","open":12.57,"high":12.67,"low":11.96,"amount":37525570.880252,"amplitude":0.056171,"askPrice":12.5,"askSize":115,"bidPrice":12.25,"bidSize":124,"shortable":3,"etf":0,"ttmEps":-4.480042,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1493870400000,"exchange":"NYSE","adjPreClose":12.34,"preHourTrading":{"tag":"盘前","latestPrice":12.3377,"preClose":12.34,"latestTime":"05:27 EDT","volume":4,"amount":49.3577,"timestamp":1789550832889,"change":-0.0023,"changeRate":-0.000186,"amplitude":0.000186},"postHourTrading":{"tag":"盘后","latestPrice":12.43,"preClose":12.34,"latestTime":"19:30 EDT","volume":62000,"amount":765288.8925,"timestamp":1789515006931,"change":0.09,"changeRate":0.007293,"amplitude":0.013776},"volumeRatio":0.8130979190340858,"impliedVol":0.7816,"impliedVolPercentile":0.128},"requestUrl":"/m/hq/s/BHVN","defaultTab":"news","newsList":[{"id":"1127356621","title":"美国FDA部分暂停Biohaven癫痫药物试验，盘前股价大跌9.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127356621","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127356621?lang=zh_cn&edition=full","pubTime":"2026-09-10 18:22","pubTimestamp":1789035734,"startTime":"0","endTime":"0","summary":"Biohaven Pharmaceutical Holding Co Ltd.股价在盘前交易时段重挫9.1%。这一跌幅的直接导火索，源于美国食品药品监督管理局对其癫痫药物试验项目祭出\"部分临床暂停\"令。Biohaven方面尚未就FDA此举的后续应对方案作出详细说明，但业界普遍认为，监管层面的这一干预可能意味着试验设计、安全性数据或执行环节存在需要修正的疑问点。在盘前交易数据的映照下，Biohaven股价的这一跌势，无疑为其近期走势增添了厚重的不确定性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHVN","LU1093756325.SGD","BK4139","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149781877","title":"Biohaven：FDA于2026年9月4日发布部分临床暂停，Bhv-7000新患者入组叫停——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1149781877","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149781877?lang=zh_cn&edition=full","pubTime":"2026-09-10 18:15","pubTimestamp":1789035311,"startTime":"0","endTime":"0","summary":"Biohaven公司在一份提交给美国证券交易委员会的文件中透露，美国食品药品监督管理局已对其实验性药物Bhv-7000发布部分临床暂停令，自2026年9月4日起，该药物相关试验的新患者入组工作被迫叫停。所谓“部分临床暂停”，意味着尽管现有受试者的治疗与随访可继续推进，但新受试者的招募与入组必须立即中止。分析人士指出，部分临床暂停虽不等同于全面叫停试验，但其对研发时间表及商业化前景的影响不可小觑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","BK4139","LU1093756325.SGD","BHVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156437610","title":"Biohaven与SK生物制药达成全球战略许可协议，携手推进新型Kv7离子通道平台及癫痫候选药物Opakalim","url":"https://stock-news.laohu8.com/highlight/detail?id=1156437610","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156437610?lang=zh_cn&edition=full","pubTime":"2026-08-26 14:37","pubTimestamp":1787726233,"startTime":"0","endTime":"0","summary":"Biohaven与SK生物制药近日宣布，双方已正式签署一项具有里程碑意义的全球战略许可协议。此次合作聚焦于新型Kv7离子通道平台，以及该平台下针对癫痫治疗的领先候选药物Opakalim。根据协议条款，Biohaven将获得Opakalim及Kv7离子通道平台在全球范围内的独家开发和商业化权利。业内分析人士指出，此次合作不仅彰显了Biohaven致力于为难治性神经系统疾病患者带来突破性疗法的决心，也反映了SK生物制药对其平台技术价值的充分认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHVN","LU1093756325.SGD","LU1093756168.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177260277","title":"Biohaven将在ESMO大会上公布新型FGFR3靶向ADC药物BHV-1530的最新临床数据，该药物采用专有拓扑异构酶I（Topoix）载荷","url":"https://stock-news.laohu8.com/highlight/detail?id=1177260277","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177260277?lang=zh_cn&edition=full","pubTime":"2026-07-20 19:31","pubTimestamp":1784547105,"startTime":"0","endTime":"0","summary":"Biohaven Pharmaceutical Holding Co Ltd. 即将在欧洲肿瘤内科学会（ESMO）大会上展示其创新药物BHV-1530的最新临床试验结果。BHV-1530是一款靶向FGFR3的抗体偶联药物（ADC），其独特之处在于搭载了公司专有的拓扑异构酶I（Topoix）载荷技术。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BHVN","LU1093756168.USD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143588829","title":"Biohaven推进新型精准免疫疗法：首创胞外蛋白降解剂BHV-1300启动格雷夫斯病关键性三期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1143588829","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143588829?lang=zh_cn&edition=full","pubTime":"2026-06-29 19:30","pubTimestamp":1782732647,"startTime":"0","endTime":"0","summary":"Biohaven Pharmaceuticals在精准免疫治疗领域迈出关键一步。其首创的胞外蛋白降解剂BHV-1300，已正式启动针对格雷夫斯病的关键性三期临床试验。这标志着一种全新治疗模式的诞生。\nBHV-1300作为首款进入临床后期的胞外蛋白降解疗法，旨在精确清除导致自身免疫性疾病的特定致病蛋白。其作用机制不同于传统药物，为格雷夫斯病患者带来了新的希望。\n格雷夫斯病是一种常见的自身免疫性甲状腺疾病，目前治疗方案有限。BHV-1300的三期试验启动，是Biohaven在该领域研发实力的重要体现，也预示着精准免疫疗法可能迎来新的突破。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1093756325.SGD","BHVN","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183634827","title":"Biohaven公布癫痫新药Opakalim最新临床数据：选择性Kv7.2/7.3激活剂展现良好癫痫控制与显著差异化耐受性特征","url":"https://stock-news.laohu8.com/highlight/detail?id=1183634827","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183634827?lang=zh_cn&edition=full","pubTime":"2026-05-26 19:35","pubTimestamp":1779795359,"startTime":"0","endTime":"0","summary":"Biohaven公司近日公布了其选择性Kv7.2/7.3激活剂Opakalim在癫痫治疗领域的最新临床数据。结果显示，该药物在癫痫控制方面表现出积极效果，并且其耐受性特征与现有疗法相比呈现出显著差异化优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHVN","BK4139","LU1093756325.SGD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181629068","title":"Biohaven新型肌肉生长抑制素-激活素通路抑制剂Taldefgrobep Alfa二期肥胖研究完成患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1181629068","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181629068?lang=zh_cn&edition=full","pubTime":"2026-03-19 19:33","pubTimestamp":1773920020,"startTime":"0","endTime":"0","summary":"Biohaven制药控股公司宣布，其针对Taldefgrobep Alfa开展的二期肥胖临床研究已顺利完成患者招募工作。该创新疗法是一种新型肌肉生长抑制素-激活素通路抑制剂，此次研究进展标志着其在代谢疾病治疗领域迈出重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BHVN","LU1093756325.SGD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518227436","title":"Biohaven Ltd.盘中异动 早盘快速下挫5.19%报28.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518227436?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:30","pubTimestamp":1741613439,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时30分，Biohaven Ltd.股票出现波动，股价急速下跌5.19%。截至发稿，该股报28.31美元/股，成交量2.467万股，换手率0.02%，振幅1.05%。Biohaven Ltd.股票所在的生物技术行业中，整体涨幅为0.00%。Biohaven Ltd.公司简介：Biohaven Ltd是一家临床阶段的生物制药公司，专注于在免疫学、神经科学和肿瘤学等关键治疗领域发现、开发和商业化改变生命的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021303996403562&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021303996403562&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1093756168.USD","BHVN","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518447713","title":"Biohaven Ltd.2024财年实现净利润-8.46亿美元，同比减少107.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518447713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518447713?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449675,"startTime":"0","endTime":"0","summary":"3月9日，Biohaven Ltd.公布财报，公告显示公司2024财年净利润为-8.46亿美元，同比减少107.35%；其中营业收入为0.00美元，每股基本收益为-9.28美元。从资产负债表来看，Biohaven Ltd.总负债1.92亿美元，其中短期债务3.80百万美元，资产负债比为3.21，流动比率为3.50。机构评级：截至2025年3月9日，当前有15家机构对Biohaven Ltd.目标价做出预测，其中目标均价为62.20美元，其中最低目标价为54.00美元，最高目标价为76.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000245abef9882&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000245abef9882&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BHVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517453098","title":"大摩：维持Biohaven(BHVN.US)评级，由增持调整至增持评级, 目标价由69.00美元调整至63.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517453098","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517453098?lang=zh_cn&edition=full","pubTime":"2025-03-08 01:13","pubTimestamp":1741367594,"startTime":"0","endTime":"0","summary":"大摩：维持Biohaven(BHVN.US)评级，由增持调整至增持评级, 目标价由69.00美元调整至63.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08011348604864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BHVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517560987","title":"HC Wainwright & Co.：重申Biohaven(BHVN.US)评级，由买入调整至买入评级, 目标价由54.00美元调整至54.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517560987","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517560987?lang=zh_cn&edition=full","pubTime":"2025-03-05 00:21","pubTimestamp":1741105301,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Biohaven(BHVN.US)评级，由买入调整至买入评级, 目标价由54.00美元调整至54.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05002148523888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BHVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516672778","title":"Biohaven Ltd.股价重挫11.81% 市值跌3.38亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516672778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516672778?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:36","pubTimestamp":1741099007,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时36分，Biohaven Ltd.股票出现异动，股价快速下挫11.81%。截至发稿，该股报28.28美元/股，成交量21.2319万股，换手率0.21%，振幅12.03%。Biohaven Ltd.股票所在的生物技术行业中，整体涨幅为0.17%。Biohaven Ltd.公司简介：Biohaven Ltd是一家临床阶段的生物制药公司，专注于在免疫学、神经科学和肿瘤学等关键治疗领域发现、开发和商业化改变生命的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223647989bada4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223647989bada4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1093756168.USD","BHVN","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516634936","title":"Biohaven Ltd.盘中异动 早盘大幅跳水5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516634936?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:35","pubTimestamp":1741012542,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时35分，Biohaven Ltd.股票出现波动，股价大幅跳水5.35%。Biohaven Ltd.股票所在的生物技术行业中，整体涨幅为0.27%。Biohaven Ltd.公司简介：Biohaven Ltd是一家临床阶段的生物制药公司，专注于在免疫学、神经科学和肿瘤学等关键治疗领域发现、开发和商业化改变生命的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223542989a1082&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223542989a1082&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1093756325.SGD","BHVN","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513739214","title":"Biohaven Ltd.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513739214","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513739214?lang=zh_cn&edition=full","pubTime":"2025-02-22 04:19","pubTimestamp":1740169182,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日04时19分，Biohaven Ltd.股票出现异动，股价急速下挫5.01%。截至发稿，该股报37.78美元/股，成交量37.7818万股，换手率0.37%，振幅7.61%。Biohaven Ltd.股票所在的生物技术行业中，整体涨幅为0.27%。Biohaven Ltd.公司简介：Biohaven Ltd是一家临床阶段的生物制药公司，专注于在免疫学、神经科学和肿瘤学等关键治疗领域发现、开发和商业化改变生命的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222041943988e260c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222041943988e260c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","BHVN","LU1093756325.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512194064","title":"Biohaven Ltd.盘中异动 临近收盘大幅跳水5.00%报39.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512194064","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512194064?lang=zh_cn&edition=full","pubTime":"2025-02-19 04:45","pubTimestamp":1739911507,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日04时45分，Biohaven Ltd.股票出现波动，股价快速下跌5.00%。截至发稿，该股报39.36美元/股，成交量63.1071万股，换手率0.62%，振幅7.13%。Biohaven Ltd.股票所在的生物技术行业中，整体涨幅为0.76%。Biohaven Ltd.公司简介：Biohaven Ltd是一家临床阶段的生物制药公司，专注于在免疫学、神经科学和肿瘤学等关键治疗领域发现、开发和商业化改变生命的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219044508988a37a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219044508988a37a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BHVN","LU1093756325.SGD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510358147","title":"Biohaven(BHVN.US)获德银首次覆盖，给予买入评级, 目标价65.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510358147","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510358147?lang=zh_cn&edition=full","pubTime":"2025-02-12 02:02","pubTimestamp":1739296955,"startTime":"0","endTime":"0","summary":"Biohaven(BHVN.US)获德银首次覆盖，给予买入评级, 目标价65.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12020248092617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BHVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510387040","title":"Biohaven Ltd.盘中异动 股价大涨8.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510387040","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510387040?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:31","pubTimestamp":1739284298,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时31分，Biohaven Ltd.股票出现异动，股价快速拉升8.03%。Biohaven Ltd.股票所在的生物技术行业中，整体跌幅为0.92%。Biohaven Ltd.公司简介：Biohaven Ltd是一家临床阶段的生物制药公司，专注于在免疫学、神经科学和肿瘤学等关键治疗领域发现、开发和商业化改变生命的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223138a241fafe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223138a241fafe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1093756168.USD","BHVN","LU1093756325.SGD","OCEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504194555","title":"Biohaven Ltd.盘中异动 急速上涨5.05%报37.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504194555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504194555?lang=zh_cn&edition=full","pubTime":"2025-01-18 01:18","pubTimestamp":1737134303,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日01时18分，Biohaven Ltd.股票出现波动，股价大幅拉升5.05%。截至发稿，该股报37.66美元/股，成交量44.2345万股，换手率0.44%，振幅4.32%。Biohaven Ltd.股票所在的生物技术行业中，整体涨幅为0.70%。Biohaven Ltd.公司简介：Biohaven Ltd是一家临床阶段的生物制药公司，专注于在免疫学、神经科学和肿瘤学等关键治疗领域发现、开发和商业化改变生命的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118011823986a3959&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118011823986a3959&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1093756325.SGD","LU1093756168.USD","BHVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503431505","title":"Biohaven Ltd.盘中异动 快速下跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503431505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503431505?lang=zh_cn&edition=full","pubTime":"2025-01-15 00:13","pubTimestamp":1736871234,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日00时13分，Biohaven Ltd.股票出现异动，股价大幅下跌5.22%。截至发稿，该股报35.52美元/股，成交量25.6379万股，换手率0.25%，振幅4.28%。Biohaven Ltd.股票所在的生物技术行业中，整体跌幅为0.18%。Biohaven Ltd.公司简介：Biohaven Ltd是一家临床阶段的生物制药公司，专注于在免疫学、神经科学和肿瘤学等关键治疗领域发现、开发和商业化改变生命的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115001354a221cfbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115001354a221cfbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1093756325.SGD","BHVN","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503584237","title":"Biohaven Ltd.盘中异动 早盘快速下挫5.09%报34.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503584237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503584237?lang=zh_cn&edition=full","pubTime":"2025-01-13 23:25","pubTimestamp":1736781916,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日23时25分，Biohaven Ltd.股票出现异动，股价大幅下跌5.09%。截至发稿，该股报34.85美元/股，成交量12.2669万股，换手率0.12%，振幅5.52%。Biohaven Ltd.股票所在的生物技术行业中，整体跌幅为1.47%。Biohaven Ltd.公司简介：Biohaven Ltd是一家临床阶段的生物制药公司，专注于在免疫学、神经科学和肿瘤学等关键治疗领域发现、开发和商业化改变生命的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113232517aba93eb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113232517aba93eb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BHVN","KAIR","LU1093756325.SGD","LU1093756168.USD","BK4139","KAPA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biohaven.com","stockEarnings":[{"period":"1week","weight":-0.1617},{"period":"1month","weight":-0.1571},{"period":"3month","weight":-0.094},{"period":"6month","weight":0.3772},{"period":"1year","weight":-0.1019},{"period":"ytd","weight":0.093}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":-0.0244},{"period":"3month","weight":0.0222},{"period":"6month","weight":0.1479},{"period":"1year","weight":0.146},{"period":"ytd","weight":0.1107}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Biohaven Ltd.是一家于2022年5月2日在英属维尔京群岛注册成立的英属维尔京群岛商业有限公司。该公司是一家生物制药公司，专注于关键治疗领域改变生命的治疗方法的发现、开发和商业化，包括免疫学、神经科学和肿瘤学。该公司正在推进创新疗法组合，利用经过验证的药物开发经验和多个专有药物开发平台。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.071849},{"month":2,"riseRate":0.222222,"avgChangeRate":-0.026101},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.120539},{"month":4,"riseRate":0.555556,"avgChangeRate":0.027819},{"month":5,"riseRate":0.666667,"avgChangeRate":0.144578},{"month":6,"riseRate":0.6,"avgChangeRate":0.085557},{"month":7,"riseRate":0.5,"avgChangeRate":0.000445},{"month":8,"riseRate":0.7,"avgChangeRate":0.052139},{"month":9,"riseRate":0.7,"avgChangeRate":0.067194},{"month":10,"riseRate":0.555556,"avgChangeRate":-0.072057},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.042561},{"month":12,"riseRate":0.555556,"avgChangeRate":0.054983}],"exchange":"NYSE","name":"Biohaven Pharmaceutical Holding Co Ltd.","nameEN":"Biohaven Pharmaceutical Holding Co Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biohaven Pharmaceutical Holding Co Ltd.(BHVN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Biohaven Pharmaceutical Holding Co Ltd.(BHVN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Biohaven Pharmaceutical Holding Co Ltd.,BHVN,Biohaven Pharmaceutical Holding Co Ltd.股票,Biohaven Pharmaceutical Holding Co Ltd.股票老虎,Biohaven Pharmaceutical Holding Co Ltd.股票老虎国际,Biohaven Pharmaceutical Holding Co Ltd.行情,Biohaven Pharmaceutical Holding Co Ltd.股票行情,Biohaven Pharmaceutical Holding Co Ltd.股价,Biohaven Pharmaceutical Holding Co Ltd.股市,Biohaven Pharmaceutical Holding Co Ltd.股票价格,Biohaven Pharmaceutical Holding Co Ltd.股票交易,Biohaven Pharmaceutical Holding Co Ltd.股票购买,Biohaven Pharmaceutical Holding Co Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biohaven Pharmaceutical Holding Co Ltd.(BHVN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Biohaven Pharmaceutical Holding Co Ltd.(BHVN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}